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ABSTRACT 42 
The endometrium becomes receptive to the embryo only in the mid-luteal phase, but not other stages of 43 
the menstrual cycle. Endometrial factors play an important role in implantation. Women with recurrent 44 
miscarriage and recurrent implantation failure have both been reported to have altered expression of 45 
receptivity markers during the window of implantation. We aimed to compare the gene expression 46 
profiles of the endometrium in the window of implantation among women with unexplained recurrent 47 
implantation failures (RIF) and unexplained recurrent miscarriages (RM) by RNA sequencing (RNA-Seq). 48 
In total 20 patients (9 RIF and 11 RM) were recruited. In addition 4 fertile subjects were included as 49 
reference. Endometrium samples were precisely timed on the 7th day after luteal hormone surge (LH+7).   50 
All the 24 endometrium samples were extracted for total RNA. The transcriptome was determined by 51 
RNA-Seq in first 14 RNA samples (5 RIF, 6 RM, and 3 fertile). Differentially expressed genes between 52 
RM and RIF were validated by quantitative real time PCR (qPCR) in all 24 RNA samples (9 RIF, 11 RM 53 
and 4 fertile). Transcriptomic profiles of RM and RIF, but not control samples, were separated from each 54 
other by principle component analysis (PCA) and support vector machine (SVM). Complementary and 55 
coagulation cascades pathway was the significantly up-regulated in RIF while down-regulated in RM. 56 
Differentially expressed genes C3, C4, C4BP, DAF, DF and SERPING1 in complement and coagulation 57 
cascade pathway between RM and RIF were further validated by qPCR. This study compared endometrial 58 
transcriptome among patients with RIF and RM in the window of implantation; it identified differential 59 
molecular pathways in endometrium between RIF and RM, which potentially affect the implantation 60 
process. 61 
 62 
KEY WORDS: 63 
Transcriptome; Endometrium; Window of Implantation; Recurrent Miscarriage; Recurrent Implantation 64 
failure   65 
Introduction 66 
Implantation is a process when the embryo attaches to the endometrium, followed by migration and 67 
invasion into the deeper layer of the endometrium to become embedded, which involves a complex 68 
sequence of cellular and molecular changes. There are two well defined categories of reproductive failure 69 
attributable to implantation disorders, namely recurrent miscarriage (RM) and recurrent implantation 70 
failure (RIF). Recurrent implantation failure refers to failure to achieve a clinical pregnancy after transfer 71 
of at least four good-quality embryos in a minimum of three cycles in a woman under the age of 40 years 72 
(Coughlan et al. 2014). The failure usually occurs at an earlier stage, resulting in complete failure to 73 
implant or failure to establish the pregnancy. On the other hand, recurrent miscarriage is defined as three 74 
or more consecutive clinical miscarriages (Saravelos & Li 2012). It commonly manifests as pregnancy 75 
loss later on in the pregnancy, often around 6-8 weeks gestation.  76 
A number of earlier studies suggested that the endometrium in unexplained RM and RIF shared some 77 
common pathological changes. For example, both uNK cell count and interleukin 15 expressions have 78 
been reported to be increased in the two conditions (Tuckerman et al. 2007, Tuckerman et al. 2010) On 79 
the other hand, certain molecules have been found to be deranged in one condition but not the other. A 80 
notable example is beta3 integrin, which is down regulated in RM (Germeyer et al. 2014) but not in RIF 81 
(Coughlan et al. 2013); whereas leukaemia inhibitory factor is down regulated in RIF (Mariee et al. 2012), 82 
but not in RM (Xu et al. 2012, Karaer et al. 2014).  In most of these earlier studies, only one specific 83 
marker was examined, with the exception of a few which examined up to 3 specific markers at the same 84 
time (Xu et al. 2012). The study of a single or a few biomarkers has a limited value especially in the case 85 
of implantation as it is a rather complex process involving several well recognized steps (apposition, 86 
adhesion, and invasion including angiogenesis) (Fitzgerald et al. 2008), each of which involves many 87 
molecules.   88 
An alternative approach which enables the simultaneous study of all different molecules involved in 89 
the implantation process is transcriptomic study by using micro-array analysis or RNA sequencing (RNA-90 
Seq). Several studies have used this approach to examine the endometrium in the peri-implantation period 91 
but they focused either on the changing transcriptome profiles before and during the window of 92 
implantation (Diaz-Gimeno et al. 2011, Hu et al. 2014), or in a specific population such as PCOS (Qiao et 93 
al. 2008), RIF (Koler et al. 2009, Altmae et al. 2010, Ruiz-Alonso et al. 2013, Koot et al. 2016) or RM 94 
(Othman et al. 2012, Kosova et al. 2015), or under the impact of  different hormonal treatment (Mirkin et 95 
al. 2004, Haouzi et al. 2009). However, none of the earlier studies employed the RNA sequencing to 96 
compare and contrast the transcriptome profiles of endometrium in unexplained RM and RIF.  97 
More recently, Brosen et al (Teklenburg et al. 2010, Brosens et al. 2014, Macklon & Brosens 2014) 98 
hypothesized that RM is associated with an over-receptive endometrium which would allow defective or 99 
abnormal embryos to implant and in turn leads to super-fertility, but followed by an increased risk of 100 
miscarriage of an abnormal embryo. In contrast, in women with RIF, implantation often fails to take place 101 
despite the replacement of many good quality embryos, implying that the defect is in the endometrium 102 
which is less receptive. The underlying molecular mechanism of altered endometrium receptivity during 103 
window of implantation in RM and RIF are still unclear.  104 
In this study, we wish to directly compare the transcriptome profiles of RM and RIF, on precisely 105 
timed endometrial specimens obtained seven days after the LH surge (LH+7) with a view to establishing 106 
to what extent RM and RIF represent two ends of the spectrum of implantation disorder. 107 
 108 
Materials and Methods 109 
Subjects  110 
    Subjects were recruited from the Prince of Wales Hospital, Chinese University of Hong Kong. The 111 
inclusion criteria of all subjects recruited include: age no more than 40 years, with regular cycles (25-35 112 
day), had not used steroid hormone in the preceding 2 months. Women with one or more of the following 113 
situations were excluded: peripheral blood showing chromosomal anomaly, tested positive for 114 
anticardiolipin antibody or lupus anticoagulant, abnormal thyroid function test, uncorrected uterine 115 
anomalies, intra-uterine device in situ, intrauterine adhesions or serious systematic disease. Women with 116 
unexplained RIF was defined as failure to achieve a clinical pregnancy after transfer of at least four good-117 
quality embryos in a minimum of three cycles in a woman under the age of 40 years, in whom routine 118 
investigations had not uncover any obvious cause (Coughlan et al. 2014). Unexplained RM was defined 119 
as three or more consecutive miscarriages before 24 weeks of gestation, with no identifiable cause after 120 
routine investigations according to an established  protocol (Saravelos & Li 2012). Fertile control subjects 121 
referred to women who had one or more live birth following spontaneous conception, stopped 122 
breastfeeding for more than 6 months, and without any history of spontaneous miscarriage, were also 123 
included as reference. In total, 14 women were recruited for transcriptome sequencing as screening, 5 124 
women with unexplained RIF, 6 women with unexplained RM, and 3 fertile. For validation, additional 10 125 
women were included, with 4 unexplained RIF, 5 unexplained RM and 1 fertile. 126 
Endometrial sample 127 
    In the cycle of study, all subjects started daily urine LH test from day 9 of the cycle onwards until the 128 
LH surge had been identified. An endometrial biopsy was obtained on day LH+7 as an outpatient 129 
procedure with the use of a Pipelle® sampler. The samples were immediately snap-frozen and stored in 130 
liquid nitrogen for later processing.  131 
RNA extraction and expression calculation  132 
    For the first batch of 14 recruited samples (5 with RIF, 6 with RM, 3 fertile), total RNA was extracted 133 
from endometrium by TRIzol according to manufacturer’s protocols (Invitrogen). RNA quality and 134 
integrity was confirmed by NanoDrop 2000 (Thermo Scientific) and Bioanalyzer 2100 Eukaryote Total 135 
RNA Pico (Agilent Tech, Inc), respectively. All 14 extracted RNA samples were rRNA depleted by 136 
Ribozero (Illumina) and the paired-ends strand-specific libraries were prepared by TrueSeq Stranded 137 
Total RNA Library Prep Kit (Illumina). All samples were sequenced by Illumina HiSeq2000. After 138 
sequencing, low quality reads whose sequencing quality below 20 were trimmed. All reads were mapped 139 
to human genome hg38 by Tophat2(Kim et al. 2013) with default parameters. The Reads Per Kilobase 140 
Per Million Reads (RPKM) of gene expression was calculated based on the GENCODE v23 annotation 141 
(Harrow et al. 2012). All expressions were normalized by quantile normalization method using median 142 
(Risso et al. 2014). The differential expressed genes (DEGs) were determined by two criteria: (a) the fold 143 
change between the means of groups was higher than 1.5; and (b) the p-value calculated from pooled T-144 
test was smaller than 0.05. 145 
Hierarchical clustering and principle component analysis (PCA) 146 
The expressions of each gene were firstly scaled as follow: 147 
𝑆𝑖𝑗 =
𝑅𝑖𝑗
max⁡(𝑅𝑖)
        148 
where 𝑆𝑖𝑗 is the scaled expression of gene i in sample j, 𝑅𝑖𝑗 is the raw normalized expression of gene i in 149 
sample j, max⁡(𝑅𝑗) is the largest value of gene i among all samples from RM, RIF and fertile groups. 150 
Afterwards the scaled expressions will be used for unsupervised hierarchical clustering and then PCA by 151 
R packages gplots (Warnes et al. 2009) and prcomp.  152 
After PCA was done, the vector of each principle component was calculated. In the space constructed 153 
by any two principle components 𝑽𝒑 and 𝑽𝒒, the direction of classification which was vertical to the 154 
calculated boundary 𝑎𝑃 + 𝑏𝑄 = 𝑐 by SVM is 𝑽𝑫 =⁡ [
𝑎
𝑏
], where 𝑎2 + 𝑏2 = 1. Thus the contribution of 155 
each gene to the classification direction was calculated by:  156 
𝑎𝑽𝒑 + 𝑏𝑽𝒒 =⁡X 157 
where X contains the contribution of the corresponding genes to the classification direction. Support 158 
vector machine (SVM) was performed by Python library sklearn 0.17.0 (Pedregosa 2011). Genes whose 159 
absolute values of the contribution scores were larger or equal to 0.01 were considered to have significant 160 
contribution. 161 
Gene ontology and pathway analysis 162 
    Only genes with significant differential expression were retrieved for gene ontology (GO) and pathway 163 
analysis. Pathway enrichment was analyzed by DAVID 6.7 (the Database for Annotation, Visualization 164 
and Integrated Discovery) (Risso et al. 2014). The pathways whose correlated p-value (q-value) smaller 165 
than 0.05 were considered significantly enriched. 166 
Quantitative RT-PCR 167 
    In additional to the 14 sequenced samples, extra 10 independent samples (4 RIF, 5 RM, and 1 fertile) 168 
were added to measure relative gene expression using quantitative real-time RT-PCR (qPCR) for 169 
validation.  TATA-box binding protein (TBP) and ribosomal protein L13a (RPL13A) were used as 170 
reference genes for expression normalization. Total RNA was extracted and quality checked as above. 171 
One microgram of total RNA was used for reverse transcription. Quantitative PCR was performed by 172 
using SYBR® Green PCR Master Mix (Applied Biosystems) with Roche LightCycler® 480 II. Primer 173 
sequences can be found in Supplementary Table 1. Wilcoxon test was used to exam the statistical 174 
significance between RIF and RM. 175 
Ethics 176 
This study was approved by the Joint Chinese University of Hong Kong – New Territories East Cluster 177 
Clinical Research Ethics Committee. Written consent was obtained from all participants. 178 
 179 
Results 180 
The demographics of the recruited subjects are summarized in Table 1. There was no significant 181 
difference in age, BMI, cycle length and endometrium thickness at the time of biopsy amongst RIF, RM 182 
and fertile groups ( Table 1).  183 
The reads mapping of all 14 samples for RNA-Seq were satisfactory (Supplementary Figure 1). All 184 
samples had over 80% reads mapped to the human genome hg38. The raw sequencing data was uploaded 185 
to NCBI with reference BioProject ID: PRJNA314429. Firstly, we explored whether RM, RIF and fertile 186 
samples could be separated in the transcriptome profiling. After normalization and scaling of gene 187 
expressions, un-supervised hierarchical clustering was performed to all samples (Figure 1). Most RIF and 188 
RM samples were clustered to two sub-trees, while fertile samples could not be grouped and were 189 
clustered within RIF or RM samples. There were 661 genes significantly up-regulated in RIF compared 190 
with RM; whilst 301 genes up-regulated in RM compared with RIF. To further compare and contrast the 191 
differences between RIF and RM, fertile samples were excluded and principle component analysis (PCA) 192 
was performed. RIF and RM samples showed distinct spatial distribution in the three-dimensional space 193 
constructed by the first three components. In the space constructed by the first component and the third 194 
component, RIF and RM were perfectly linear separated (Figure 2). The boundary between RIF and RM 195 
could be further learnt by SVM, where the classification direction which was vertical to the linear 196 
boundary gave the best resolution to distinguish RIF and RM. To identify the genes that contribute the 197 
most to the classification direction, the contribution score for each gene was calculated (see Method). The 198 
genes with positive contribution scores showed higher expressions in RM, while genes with negative 199 
contribution scores showed higher expressions in RIF (Figure 3). Genes whose absolute values of 200 
contribution scores were larger or equal to 0.01 were considered to have significant contribution to the 201 
classification of RIF and RM, where 183 genes had significant positive contribution and 380 had 202 
significant negative contribution.  203 
    To investigate which biological and molecular pathway contributed most to the differential 204 
transcriptomic pattern between RIF and RM, pathway enrichment analysis was applied on genes with 205 
significant contribution on both directions (Figure 3). Pathways with –log(q-value) > 2 were considered 206 
as significant. The localization of proteins encoded by genes in both directions showed high enrichment in 207 
extracellular regions indicated by GO cellular component terms. However, the pathways where they were 208 
involved were distinct, which could be revealed by GO biological process terms and KEGG pathways 209 
(Figure 4). On negative direction, many responses to wounding and inflammatory genes were 210 
predominately enriched, including the most enriched complement and coagulation cascades in KEGG 211 
(Figure 5). Several central components of complement and coagulation cascades have significantly higher 212 
expressions in RIF than those in RM, with significant t-test p-values less than 0.05. We chose the top six 213 
over-expressed genes in RIF from complement cascade, namely C3, C4, C4BP, DAF, DF and SERPING1, 214 
for real time PCR validation (Figure 6). In contrast, on positive direction, genes that were involved in 215 
extracellular structure organization and biological adhesion by GO biological process terms and 216 
neuroactive ligand-receptor interaction and calcium signaling pathways in KEGG, were significantly 217 
enriched, but only few (2/78) significant differentially expressed genes were identified. 218 
Real time PCR was performed on all 24 samples to validate the differential expression of 6 genes in 219 
complement cascade (Figure 6). All the gene expressions were significantly up-regulated in RIF group 220 
compared with that of RM with Wilcoxon test, p values less than 0.05. However, the real time PCR 221 
results of control group showed great variation, and most of the difference are not significant. 222 
 223 
Discussion 224 
In this study, we have found that the transcriptome profiles of the two groups of patients studied (RM 225 
and RIF) are distinctively different from one another. In addition, we have found significant amounts of 226 
differentially expressed genes (661 up-regulated in RIF and 301 up-regulated in RM) and one 227 
distinctively and validated pathway between women with RIF and RM. 228 
Among all the enriched pathways, the complement and coagulation cascades pathway was the most 229 
significantly affected pathway with -log(q-values) >4 in KEGG pathway analysis in RIF. This particular 230 
pathway was upregulated in RIF patients compared with RM patients, the genes involved in this pathway 231 
included C3, C4, C4BP, DAF, DF and SERPING1. All of these 6 up-regulated genes had been validated 232 
with qPCR, which confirmed the up-regulation generally existed in patients with unexplained RIF. 233 
Reference to Figure 6 showed that C3 expression in RIF was significantly higher than that of control,  234 
whereas the expression in RM was not different to that of control subjects. The complement system, 235 
represented by complement component 3 (C3), is a proteolytic cascade in plasma and an upstream 236 
mediator of innate immunity. It is known that human chorionic gonadotropin (hCG) has positive effects 237 
on endometrial C3 expression (Palomino et al. 2013). Whilst the adverse effect of decreased C3 238 
expression on placental development and fetal development has been shown in C3 deficient mice (Chow 239 
et al. 2009), and variants in FOXD1 that enhance the expression of C3 were associated with miscarriage 240 
in humans and mice (Laissue et al. 2016). tThe possible adverse effect of over expression of C3 has not 241 
been previously reported. It seems therefore a fine balance is necessary; both under expression as well as 242 
over expression of C3 may be detrimental. Our observation that the C3 was over expressed in RIF but not 243 
in RM suggested that the two conditions affect uterine receptivity in different ways. One of the major 244 
immune functions of C3 pathway is to form the membrane attack complex, leading to cell lysis (Ricklin et 245 
al. 2010). While DAF (complement-protective protein decay-accelerating factor, also known as CD55) 246 
was considered as an inhibitor to the increased complement activity (Young et al. 2002) and expression of 247 
DAF was minimal in the proliferative and early secretory phase in endometrium, increased to a maximum 248 
on LH+7, and decreased until next cycle. Endometrial C3 and DAF expression was associated with 249 
human chorionic gonadotropin, indicating its roles in early embryo development (Palomino et al. 2013). 250 
Whilst there has not been any study in the literature which reported on the expression of any of the genes 251 
involved in this pathway in the endometrium of RIF or RM at the time of implantation, previous genetic 252 
association studies found the loss of functional mutation of some genes in this pathway were associated 253 
with RM (Mohlin et al. 2013) or other adverse pregnancy outcome, such as preeclampsia (Salmon et al. 254 
2011). Although both C3 and DAF were upregulated in RIF when compared with RM, the increased C3 255 
expression (3.5 folds) was higher than the increased DAF expression (2.8 folds), suggesting the inhibitory 256 
complement system in RIF may be more likely a reactive response. Further studies of its inhibitory 257 
mechanism and subsequent downstream innate immune response in RIF are needed.  258 
On the other hand, though the neuroactive ligand-receptor interaction pathway and calcium signaling 259 
pathway were enriched in RM according to the positively contributed gene list from SVM analysis, we 260 
did not consider them as important as the complement and coagulation cascades pathway as discussed 261 
above. Firstly, most of the genes with positive contribution in these two pathways were expressed at very 262 
low expression level. Furthermore, almost no differentially expressed genes were identified in those two 263 
pathways. One explanation for lack of significantly expressed genes in calcium pathway in our study 264 
could be that this activity could be prominent in endometrial epithelium cells (Thie & Denker 2002, 265 
Brosens et al. 2014, Ruan et al. 2014), which might be diluted if sequencing endometrium tissue as a 266 
whole. However, it has long been known that Ca
2+
 channels involves in a variety of implantation 267 
processes and increased Ca
2+
 mobilization can assist blastocyst-endometrium adhesion (Thie & Denker 268 
2002, Brosens et al. 2014, Ruan et al. 2014). Brosen et al. found that competent and low-quality embryos 269 
elicited different Ca
2+
 channel responses in vitro, which indicate the active role of endometrial selective 270 
function of human embryos (Brosens et al. 2014). And this selection was impaired in the endometrium of 271 
RM subjects (Teklenburg et al. 2010). In this study, the genes with positive contribution in calcium 272 
signaling pathway may suggest the higher activity of the Ca
2+
 channel in the endometrium of RM 273 
compared with that of RIF. It might indicate that the endometrium during WOI is more favorable for 274 
implantation in RM compared with RIF, which would also be in consistent with in vitro study carried out 275 
by Brosens et al. that pattern of Ca
2+ 
signals was associated with the implantation results.  276 
According to the hypothesis put forward by Brosen and Macklon et al (Teklenburg et al. 2010, Brosens 277 
et al. 2014, Macklon & Brosens 2014), women with unexplained RM would be superfertile because the 278 
endometrium is over-receptive, less able to discern and prevent the abnormal embryos from implantation, 279 
in contrast to that of women with RIF, in which the abnormality makes it difficult for even the normal 280 
embryo to implant. Whilst our findings do not directly confirm or refute the Brosen hypothesis that the 281 
endometrium is over-receptive in women with RM, our finding regarding the differential regulation of the 282 
pathways between the two groups of women may provide insight into the molecular mechanism 283 
controlling the implantation process in the endometrium to make it under-receptive (as in women with 284 
RIF) or over-receptive (as in women with RM). 285 
The transcriptome pattern of fertile women seems dispersedly distributed among RIF and RM subjects, 286 
but the sample size in our study indeed is very small to make any conclusion. The dispersed distribution 287 
may be due to the heterogeneity of endometrial receptivity status. Although they were classified as fertile 288 
controls as they had previously successful pregnancy in early years, unfortunately it does not necessarily 289 
imply they will still be able to achieve successful pregnancy if conceived. This is one of the limitations of 290 
our study. 291 
A particular strength of our study is the precise timing of the endometrial specimen, all obtained on day 292 
LH+7. Whilst some earlier studies did time the specimen precisely on a single day (Diaz-Gimeno et al. 293 
2011, Hu et al. 2014) others obtained the specimen over two or more days (Ledee et al. 2011, Koot et al. 294 
2016). Given that the endometrium changes very rapidly around the time of implantation, the inclusion of 295 
samples collected on different days after the LH surge could introduce a significant source of variance to 296 
the results. It may help to explain why, in a previous study by Ledee et al. which studied similar subjects 297 
groups as in our study but with biopsies obtained over a three-day period from days LH+7 to +9, they 298 
could find gene expression differences between RM and RIF, consistent with our findings, but not able to 299 
identify the pathways (Ledee et al. 2011).  300 
Another strength of this study is that we used RNA-seq rather than micro-array to analyze the 301 
specimens. Earlier transcriptome studies of the endometrium used micro-array analysis (Ledee et al. 2011, 302 
Othman et al. 2012, Ruiz-Alonso et al. 2013, Koot et al. 2016) although 2 recent studies did use 303 
sequencing techniques (Hu et al. 2014, Kosova et al. 2015).  It is now well accepted that sequencing 304 
technique is more comprehensive in coverage and precise in quantification of global gene expression 305 
profiles (McGettigan 2013). Furthermore, in our study we have used more straightforward and more 306 
comprehensive methods to mine the features which contributed to the classification of the two groups of 307 
women, and thus identified genes and pathways that were differentially expressed between RIF and RM. 308 
The chosen testing platforms and analysis methods could also greatly contributed to the identification of 309 
significant pathways.  310 
One possible limitation of our study is the relatively small sample size (RIF=9, RM=11, control=4) and 311 
so the conclusions reached in this study should be considered preliminary, especially in view of the 312 
potential heterogeneity of the study populations. 313 
To conclude, we have identified that the complement and coagulation cascades pathway are 314 
significantly different between women with RM and RIF. The identified pathways provide an insight into 315 
how the process of implantation in these two types of implantation disorder differs from one other. 316 
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